508 related articles for article (PubMed ID: 21854888)
1. Cardiac resynchronization therapy: what? Who? When? How?
Cuculich PS; Joseph S
Am J Med; 2011 Sep; 124(9):813-5. PubMed ID: 21854888
[TBL] [Abstract][Full Text] [Related]
2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
3. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
Bristow MR; Saxon LA; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; DeMets D; White BG; DeVries DW; Feldman AM;
N Engl J Med; 2004 May; 350(21):2140-50. PubMed ID: 15152059
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
Balmain S; McDonald MA
Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1147-53. PubMed ID: 21932957
[TBL] [Abstract][Full Text] [Related]
5. Heart rates in cardiac resynchronization: the art of optimal device programming.
Maass AH; van Veldhuisen DJ
Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
[No Abstract] [Full Text] [Related]
6. Cardiac resynchronization therapy for treatment of heart failure.
Ho JK; Mahajan A
Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
[TBL] [Abstract][Full Text] [Related]
7. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy.
Delgado V; van Bommel RJ; Bertini M; Borleffs CJ; Marsan NA; Arnold CT; Nucifora G; van de Veire NR; Ypenburg C; Boersma E; Holman ER; Schalij MJ; Bax JJ
Circulation; 2011 Jan; 123(1):70-8. PubMed ID: 21173353
[TBL] [Abstract][Full Text] [Related]
8. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
Ansalone G; Ricci R; Cacciatore G; Santini M
Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
[TBL] [Abstract][Full Text] [Related]
9. Device therapy in Chagas disease heart failure.
Bestetti RB; Cardinalli-Neto A
Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1307-17. PubMed ID: 23190069
[TBL] [Abstract][Full Text] [Related]
10. Biventricular pacing and defibrillator use in chronic heart failure.
Cesario DA; Turner JW; Dec GW
Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular lead placement in cardiac resynchronization therapy: where and how?
Khan FZ; Virdee MS; Fynn SP; Dutka DP
Europace; 2009 May; 11(5):554-61. PubMed ID: 19372115
[TBL] [Abstract][Full Text] [Related]
12. Effect of digoxin on shocks in cardiac resynchronization therapy-defibrillator patients with coronary artery disease.
Adelstein E; Schwartzman D; Jain S; Bazaz R; Saba S
Am J Cardiol; 2014 Mar; 113(6):970-5. PubMed ID: 24440327
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac resynchronization therapy-always with ICD?].
Stellbrink C
Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
[TBL] [Abstract][Full Text] [Related]
14. Pathobiology of left ventricular dyssynchrony and resynchronization.
Spragg DD; Kass DA
Prog Cardiovasc Dis; 2006; 49(1):26-41. PubMed ID: 16867848
[TBL] [Abstract][Full Text] [Related]
15. Cardiac resynchronization therapy with or without an implantable defibrillator: only indicated when everything else has failed?
Ghosh J; Kaye G; Cleland JG
Card Electrophysiol Rev; 2003 Dec; 7(4):421-9. PubMed ID: 15071268
[TBL] [Abstract][Full Text] [Related]
16. A futuristic perspective on clinical studies of cardiac resynchronization therapy for heart failure patients.
Tang AS; Ellenbogen KA
Curr Opin Cardiol; 2006 Mar; 21(2):78-82. PubMed ID: 16470139
[TBL] [Abstract][Full Text] [Related]
17. Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor.
Ståhlberg M; Kessels R; Linde C; Braunschweig F
Europace; 2011 Feb; 13(2):237-43. PubMed ID: 20952424
[TBL] [Abstract][Full Text] [Related]
18. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
Pires LA
Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
[TBL] [Abstract][Full Text] [Related]
19. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
Samii SM
Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study.
Linde C; Abraham WT; Gold MR; Daubert C;
J Am Coll Cardiol; 2010 Nov; 56(22):1826-31. PubMed ID: 21087711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
